|1R01CA249419-01 Interpret this number
|Kaiser Foundation Research Institute
|The Epics (Engaging Primary Care in Cancer Survivorship) Study: a Randomized Trial of Novel Models of Care for Cancer Survivors
Significant growth in the number of cancer patients, particularly those ≥65 years, is predicted within the U.S
over the next 20 years. The majority of these patients will enter into a prolonged post-treatment survivorship
phase of care. However, we are currently facing unprecedented challenges in survivorship care delivery.
Serious gaps in the care of survivors have been identified, including underuse of guideline-recommended
cancer surveillance services, such as annual mammography for breast cancer survivors and colonoscopy for
colorectal cancer (CRC) survivors, and underuse of recommended preventive care services such as
vaccinations, lipid testing and cardiovascular risk management, and disease screenings. Compounding these
issues, our current oncology workforce is insufficient to care for the rapidly growing population of survivors.
Primary care provider (PCP)-led survivorship care is a feasible model of survivorship care. In observational
studies, survivors who receive care that involves PCPs received higher quality of care; international
randomized trials comparing PCP-led to oncology-led survivorship care have shown no significant differences
in time to detection of cancer recurrence or quality of life for early-stage survivors. However, there is a paucity
of high-quality research on models of survivorship care in the U.S, particularly in community-based settings,
seriously limiting our ability to provide high-quality cancer survivorship care. To address these issues, we will
conduct a prospective cluster randomized trial of two models of cancer survivorship care in early-stage, low-
risk breast cancer and CRC survivors cared for in a community-based, integrated health care setting. Building
on our pilot work and drawing on the empirical literature, we will test the efficacy of an embedded PCP model
(experimental condition) in which PCPs are embedded within an oncology practice and will care for low-risk
survivors who will be transitioned at 12 months post-treatment. These PCPs will be given training in cancer
survivorship care focused on cancer surveillance and chronic disease prevention. This model will be compared
to the extant oncology physician model (usual care) that is the default condition in this healthcare system. The
primary outcome will be receipt of guideline-recommended care (e.g., cancer surveillance, preventive care),
assessed over a 36-month period. Secondary outcomes will include patient-reported outcomes using validated
measures of patient-provider communication, care coordination, quality of life, self-efficacy in managing care,
and other measures. We will also compare utilization of unplanned care (hospitalizations, urgent care) and
receipt of non-recommended care. We will explore PCP perceptions of confidence in delivery of survivorship
care. We will conduct this trial in 8 large, hospital-based medical centers of an integrated health care system,
Kaiser Permanente Southern California, with approximately 2,000 early-stage breast and CRC survivors. Our
results will provide more definitive evidence on the effectiveness of a scalable model of PCP-led survivorship
care, addressing the critical shortage of oncology providers while maintaining or improving quality.
Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer.
, Wallner L.P.
, Skolarus T.A.
, George A.K.
, Rosenberg B.H.
, Abrahamse P.
, Hawley S.T.
The Journal of urology, 2022 Sep; 208(3), p. 600-608.